Corvex Other Non-Current Liabilities increased by 7486.9% to $20.26M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4313.3%, from $459.00K to $20.26M. Over 4 years (FY 2021 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 65.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.00K | $214.00K | $168.00K | $121.00K | $50.00K | $33.00K | $623.00K | $583.00K | $520.00K | $459.00K | $396.00K | $332.00K | $267.00K | $20.26M |
| QoQ Change | — | +494.4% | -21.5% | -28.0% | -58.7% | -34.0% | >999% | -6.4% | -10.8% | -11.7% | -13.7% | -16.2% | -19.6% | >999% |
| YoY Change | — | +494.4% | — | — | -76.6% | -80.4% | +414.9% | — | +940.0% | >999% | -36.4% | -43.1% | -48.7% | >999% |